Tissue Regenix Group Plc (TRX) — Net Asset Momentum
Tissue Regenix Group Plc (TRX) recorded a net asset momentum of -1.0% as of December 2024, with net assets of GBX29.06 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Tissue Regenix Group Plc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Tissue Regenix Group Plc Net Asset Momentum (2007–2024)
This chart tracks Tissue Regenix Group Plc's year-over-year net asset growth across 20 annual reporting periods from 2007 to 2024. The most recent momentum reading is -1.0%, with net assets of GBX29.06 Million GBX as of December 2024. Read TRX total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Tissue Regenix Group Plc (2007–2024)
The table below shows the complete annual net asset history for Tissue Regenix Group Plc from 2007 to 2024, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see TRX market cap.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX29.06 Million | GBX45.35 Million | GBX16.29 Million | ▼ -1.0% |
| 2023 | GBX29.36 Million | GBX43.24 Million | GBX13.89 Million | ▲ +16.2% |
| 2022 | GBX25.27 Million | GBX38.27 Million | GBX13.00 Million | ▲ +2.5% |
| 2021 | GBX24.65 Million | GBX34.13 Million | GBX9.47 Million | ▼ -11.5% |
| 2020 | GBX27.85 Million | GBX36.73 Million | GBX8.88 Million | ▲ +13.2% |
| 2019 | GBX24.59 Million | GBX30.50 Million | GBX5.90 Million | ▼ -24.5% |
| 2018 | GBX32.57 Million | GBX37.66 Million | GBX5.09 Million | ▼ -17.6% |
| 2018 | GBX39.52 Million | GBX45.76 Million | GBX6.24 Million | ▲ +0.0% |
| 2017 | GBX39.52 Million | GBX45.76 Million | GBX6.24 Million | ▲ +242.6% |
| 2016 | GBX11.54 Million | GBX13.60 Million | GBX2.06 Million | ▼ -61.9% |
| 2016 | GBX30.25 Million | GBX33.04 Million | GBX2.79 Million | ▲ +161.3% |
| 2015 | GBX11.58 Million | GBX12.67 Million | GBX1.09 Million | ▼ -63.0% |
| 2014 | GBX31.30 Million | GBX33.13 Million | GBX1.82 Million | ▼ -19.0% |
| 2013 | GBX38.64 Million | GBX39.73 Million | GBX1.08 Million | ▼ -11.7% |
| 2012 | GBX43.78 Million | GBX44.80 Million | GBX1.02 Million | ▲ +344.9% |
| 2011 | GBX9.84 Million | GBX10.24 Million | GBX400.37K | ▲ +168.4% |
| 2010 | GBX3.67 Million | GBX3.72 Million | GBX51.12K | ▲ +0.9% |
| 2009 | GBX3.63 Million | GBX3.70 Million | GBX60.53K | ▼ -62.5% |
| 2008 | GBX9.68 Million | GBX9.77 Million | GBX83.52K | ▲ +68.8% |
| 2007 | GBX5.74 Million | GBX5.75 Million | GBX15.69K | — |